Whole Genome Sequencing: How It Works and What It Reveals

Whole genome sequencing (WGS) is the process of determining the complete DNA sequence of an organism's genome at a single time. In humans, this means sequencing approximately 3.2 billion base pairs. What once took 13 years and cost $3 billion (Human Genome Project, 1990-2003) can now be accomplished in days for less than $1,000, thanks to next-generation sequencing technologies.

How Whole Genome Sequencing Works

Modern WGS typically uses short-read sequencing technology (primarily Illumina platforms). The process begins with extracting DNA from a biological sample (blood, saliva, or tissue). The extracted DNA is fragmented into small pieces (typically 150-300 base pairs), and adapters are ligated to the fragments to create a sequencing library. The library is then loaded onto a flow cell where millions of DNA molecules are sequenced simultaneously using sequencing-by-synthesis chemistry.

Because each fragment is short, the genome must be sequenced to high depth (30x coverage means each position is read an average of 30 times) to ensure accuracy. The resulting reads are then computationally aligned to a reference genome, and variant calling algorithms identify differences between the sequenced genome and the reference.

Types of Variants Detected

WGS can detect virtually all types of genetic variants: single nucleotide variants (SNVs), small insertions and deletions (indels), copy number variations (CNVs), structural variants (inversions, translocations), and repetitive element expansions. This comprehensive coverage distinguishes WGS from targeted gene panels or whole exome sequencing, which only analyze protein-coding regions.

Clinical Applications of WGS

WGS is increasingly used in clinical medicine, particularly for rare disease diagnosis, cancer genomics, infectious disease surveillance, and pharmacogenomics. For rare disease diagnosis, WGS achieves diagnostic yields of 30-40% in cases that have been through extensive conventional testing without a diagnosis. In cancer, tumor WGS identifies somatic mutations, copy number changes, and structural variants that inform treatment selection and prognosis.

Challenges and Considerations

WGS generates enormous amounts of data (approximately 100 gigabytes per sample) requiring substantial computational infrastructure. Variant interpretation remains challenging—most WGS results include thousands of variants of uncertain significance. Storage, privacy, and the potential for incidental findings (variants revealing conditions unrelated to the original clinical question) also require careful handling and informed consent protocols.

For more on genome sequencing and its applications, visit our blog.